BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11948104)

  • 1. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease.
    Ngan RK; Yip TT; Cheng WW; Chan JK; Cho WC; Ma VW; Wan KK; Au SK; Law CK; Lau WH
    Clin Cancer Res; 2002 Apr; 8(4):986-94. PubMed ID: 11948104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical role of circulating Epstein-Barr virus DNA as a tumor marker in lymphoepithelioma-like carcinoma of the lung.
    Ngan RK; Yip TT; Cheng WW; Chan JK; Cho WC; Ma VW; Wan KK; Au JS; Law CK
    Ann N Y Acad Sci; 2004 Jun; 1022():263-70. PubMed ID: 15251971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China.
    Han AJ; Xiong M; Zong YS
    Am J Clin Pathol; 2000 Aug; 114(2):220-6. PubMed ID: 10941337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma.
    Lo YM; Chan WY; Ng EK; Chan LY; Lai PB; Tam JS; Chung SC
    Clin Cancer Res; 2001 Jul; 7(7):1856-9. PubMed ID: 11448896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Epstein-Barr virus and lymphoepithelioma-like carcinoma of the lung: a clinicopathologic study of 6 cases and review of the literature.
    Castro CY; Ostrowski ML; Barrios R; Green LK; Popper HH; Powell S; Cagle PT; Ro JY
    Hum Pathol; 2001 Aug; 32(8):863-72. PubMed ID: 11521232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma.
    Le QT; Jones CD; Yau TK; Shirazi HA; Wong PH; Thomas EN; Patterson BK; Lee AW; Zehnder JL
    Clin Cancer Res; 2005 Aug; 11(16):5700-7. PubMed ID: 16115906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
    Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC
    J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
    Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
    Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Epstein-Barr virus play a role in lymphoepithelioma-like carcinoma of the uterine cervix?
    Chao A; Tsai CN; Hsueh S; Lee LY; Chen TC; Huang SL; Chao FY; Lai CH
    Int J Gynecol Pathol; 2009 May; 28(3):279-85. PubMed ID: 19620947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study.
    Mäkitie AA; Reis PP; Irish J; Zhang T; Chin SF; Chen X; Marriott C; Keller A; Perez-Ordonez B; Kamel-Reid S; Siu LL
    Head Neck; 2004 Sep; 26(9):815-22. PubMed ID: 15350028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between the kinetics of plasma EBV DNA levels and clinical response during treatment in patients with nasopharyngeal carcinoma].
    Peng PJ; Zhao C; Liao H; Wang FQ; Zhang L
    Ai Zheng; 2002 Aug; 21(8):817-22. PubMed ID: 12478884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.
    Lo YM; Chan LY; Chan AT; Leung SF; Lo KW; Zhang J; Lee JC; Hjelm NM; Johnson PJ; Huang DP
    Cancer Res; 1999 Nov; 59(21):5452-5. PubMed ID: 10554016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.
    Jones K; Nourse JP; Keane C; Crooks P; Gottlieb D; Ritchie DS; Gill D; Gandhi MK
    Am J Hematol; 2012 Mar; 87(3):258-65. PubMed ID: 22213215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA.
    Hong RL; Lin CY; Ting LL; Ko JY; Hsu MM
    Cancer; 2004 Apr; 100(7):1429-37. PubMed ID: 15042677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study.
    Wei WI; Yuen AP; Ng RW; Ho WK; Kwong DL; Sham JS
    Head Neck; 2004 Oct; 26(10):878-83. PubMed ID: 15390201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.